M, M., N, S., A, J., M, S., S, Y., E, E., & N, A. (2026). Symptomatic candiduria in neonates, infants, and pediatric patients admitted to ICUs: Epidemiology, risk factors, clinical symptoms, and outcomes of empirical antifungal therapy. BMC infectious diseases, 26(1), . https://doi.org/10.1186/s12879-026-13493-2
Chicago Style (17th ed.) CitationM, Motamedi, Shaabani N, Jabrodini A, Shafiekhani M, Yazdanpanah S, Eghtedarnejad E, and Amirzadeh N. "Symptomatic Candiduria in Neonates, Infants, and Pediatric Patients Admitted to ICUs: Epidemiology, Risk Factors, Clinical Symptoms, and Outcomes of Empirical Antifungal Therapy." BMC Infectious Diseases 26, no. 1 (2026). https://doi.org/10.1186/s12879-026-13493-2.
MLA (9th ed.) CitationM, Motamedi, et al. "Symptomatic Candiduria in Neonates, Infants, and Pediatric Patients Admitted to ICUs: Epidemiology, Risk Factors, Clinical Symptoms, and Outcomes of Empirical Antifungal Therapy." BMC Infectious Diseases, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12879-026-13493-2.